Chapter
The Hydroxychloroquine Controversy
21:56 - 27:20 (05:23)
The controversy on hydroxychloroquine treatment for COVID-19 started with research papers suggesting its effectiveness in vitro and against SARS, prompting FDA to authorize doctors to try it in emergency trials with patients. Rapid decentralized information sharing among hospitals and doctors is also helping in finding the right answer for treating the virus.
Clips
The FDA granted emergency trial authorization for doctors to prescribe hydroxychloroquine to COVID-19 patients due to early research that showed positive results in vitro and against similar viruses like SARS, but there is still ongoing debate regarding its effectiveness for treating COVID-19.
21:56 - 27:20 (05:23)
Hydroxychloroquine
Summary
The FDA granted emergency trial authorization for doctors to prescribe hydroxychloroquine to COVID-19 patients due to early research that showed positive results in vitro and against similar viruses like SARS, but there is still ongoing debate regarding its effectiveness for treating COVID-19.